Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
68.7M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
1.04M
-
Shares change
-
+148K
-
Total reported value, excl. options
-
$5.48M
-
Value change
-
+$533K
-
Put/Call ratio
-
4.67
-
Number of buys
-
19
-
Number of sells
-
-7
-
Price
-
$5.28
Significant Holders of Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) as of Q2 2021
35 filings reported holding IRD - Opus Genetics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2021.
Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.04M shares
of 68.7M outstanding shares and own 1.51% of the company stock.
Largest 10 shareholders include MARSHALL WACE, LLP (329K shares), Ikarian Capital, LLC (120K shares), NORRIS PERNE & FRENCH LLP/MI (78.9K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (59.2K shares), STATE STREET CORP (54.6K shares), GOLDMAN SACHS GROUP INC (37.3K shares), VANGUARD GROUP INC (37.1K shares), RENAISSANCE TECHNOLOGIES LLC (35.5K shares), BlackRock Inc. (34.4K shares), and GEODE CAPITAL MANAGEMENT, LLC (25.6K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.